---

Kiran Mazumdar-Shaw

Chairperson and Managing Director of Biocon

From a tiny start-up company launched in 1978 with seed funds of Rs 10,000 and run from her garage, Kiran Mazumdar-Shaw has grown Biocon into a leading producer of generics, floated on the stock market in 2004 with a valuation of $1.1 billion. And Kiran has no plans to slow down– aiming to bring revenue up to the $1 billion mark by 2018. She is also known for her philanthropic work, through the Biocon Foundation, which provides healthcare for marginalized communities.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016